Heterogeneity of imidazoline binding sites revealed by a cirazoline derivative

Eur J Pharmacol. 1994 Dec 27;271(2-3):533-6. doi: 10.1016/0014-2999(94)90815-x.

Abstract

The affinity of AMPI (2-[3-aminophenoxy]methyl imidazoline) for [3H]clonidine and [3H]idazoxan imidazoline binding sites was determined in various rabbit and human tissues. Although cirazoline showed a high affinity (nM range) in all the tested tissues, its derivative, AMPI, had a high affinity (nM range) in rabbit brain and kidney but a low affinity (microM range) in the human brain. These differences in affinities were very similar to those obtained with amiloride. The same results were obtained when considering [3H]clonidine or [3H]idazoxan specific imidazoline binding sites.

MeSH terms

  • Animals
  • Binding Sites
  • Brain / metabolism
  • Clonidine / metabolism*
  • Dioxanes / metabolism*
  • Humans
  • Idazoxan
  • Imidazoles / metabolism*
  • Imidazoline Receptors
  • Kidney / metabolism
  • Rabbits
  • Receptors, Drug / metabolism*
  • Species Specificity

Substances

  • Dioxanes
  • Imidazoles
  • Imidazoline Receptors
  • Receptors, Drug
  • 2-amino-1-methyl-5-propylideneimidazol-4-one
  • Clonidine
  • Idazoxan